Prognostic Factor in the Patients With Benign Prostatic Hyperplasia Who Undergo Holmium Laser Enucleation of the Prostate

Samsung Medical Center432 enrolled

Overview

Prognostic factor in the patients with benign prostatic hyperplasia (BPH) who undergo holmium laser enucleation of the prostate

Study Type

OBSERVATIONAL

Enrollment

432

Conditions

Benign Prostatic Hyperplasia (BPH)

Interventions

holmium laser enucleation of the prostatePROCEDURE

undergo holmium laser enucleation of the prostate

Eligibility

Sex: MALE

Medical Language ↔ Plain English

Inclusion Criteria: * Male patient scheduled to undergo prostatectomy using holmium laser Exclusion Criteria: * Urethral stricture, large bladder diverticulum, bladder neck contracture

Locations (1)

Samsung Medical Center, Sungkyunkwan University School of Medicine

Seoul, South Korea

Outcomes

Primary Outcomes

Comparison of IPSS(International Prostate Symptom Score) changes

Complete the questionnaire(IPSS) before and after the treatment

Time frame: pre-operation and post-operation (3month, 6month)

Secondary Outcomes

changes of voided urine volume

Comparison of voided urine volume

Time frame: pre-operation and post-operation (3month, 6month)

changes of residual urine volume

Comparison of residual urine volume

Time frame: pre-operation and post-operation (3month, 6month)

Occurrence of adverse event

collection of adverse event

Time frame: post-operation (3month, 6month)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.